SecBot SecBot
SECBOTREPLAY Home › Report › NBIX

NBIX · PGR instituted on Spruce patent

NEUROCRINE BIOSCIENCES INC · PTAB-TRIAL filed Nov 9, 2026 at 19:00 ET

At the news

NEUTRALIMPACT 3/10

PTAB-TRIAL filed Nov 9, 2026 at 19:00 ET

The PTAB granted institution of post-grant review (PGR2026-00059) on Neurocrine's petition challenging Spruce Biosciences' patent covering methods for treating testicular and ovarian adrenal rest tumors. The decision is interlocutory and does not cancel any claims; a final written decision is expected within about a year.

  • PTAB granted institution of PGR2026-00059 on November 10, 2026
  • Patent U.S. 12569491 covers methods for treating testicular and ovarian adrenal rest tumors
  • Patent owner is Spruce Biosciences, Inc.; petitioner is Neurocrine Biosciences, Inc.
  • Institution is interlocutory, no claims have been cancelled

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access